Cdsco
-
{
- All
- News
- Videos
-
42 Drug Samples Found 'Not Of Standard Quality (NSQ)' In April: Health Ministry
According to routine regulatory surveillance, the list of not of standard quality (NSQ) and spurious drugs is displayed on the CDSCO portal every month.
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
Central Drug Regulator Blames Tamil Nadu Lapses For Syrup Tragedy: Sources
The central drug regulator has blamed the negligence of Tamil Nadu authorities for the cough syrup tragedy.
-
Centre Flags Carcinogen Fears On Acidity Medicine Ranitidine, Orders Probe
The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure manufacturers of Ranitidine -- a commonly used acidity medicine --monitor NDMA levels.
-
India Proposes Training Programmes For Foreign Drug Regulators
India is likely to provide practical insights to certain countries on the best practices in drug regulations and the impactful initiatives taken by the Indian drug regulators, officials said on Wednesday.
-
Paracetamol, 50 Other Drug Samples Fail Quality Test. See Full List
Popular medications like paracetamol, pantoprazole and various antibiotics failed quality tests.
-
Centre Bans Anti-Cold Fixed Drug Combination In Children Below 4 Years
The Central Drugs Standard Control Organisation (CDSCO) has prohibited the use of anti-cold fixed drug combinations in children below four years of age.
-
Rajeev Singh Raghuvanshi Appointed As Drugs Controller General Of India
The Union Public Service Commission (UPSC) has recommended the name of DrRajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).
-
Drug Regulator Draws Johnson and Johnson Baby Powder Samples For Testing
The country's top drug regulator, the CDSCO, drew samples of Johnson and Johnson's baby powder from the company's Baddi plant in Himachal Pradesh on Wednesday amid reports that the product allegedly contained cancer-causing asbestos.
-
India's Reaction To Report On Johnson And Johnson Baby Powder
India's drug regulator said on Tuesday a news agency Reuters report that Johnson & Johnson knew for decades that cancer-causing asbestos lurked in its baby powder was "under consideration".
-
Pharma Firms Can Now Export Medicines, Devices Without 'No Objection Certificate'
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring "no-objection" certificate (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
-
Probe finds 'alarming' problems with India's drug regulator
India's main drug regulator has not been properly scrutinising some drugs before approving them, and some of its officials are colluding with drug firms and medical experts to circumvent procedure, according to a new parliamentary report. The report by parliament's health committee, the result of a more than year-long investigation, painted a chaot...
-
42 Drug Samples Found 'Not Of Standard Quality (NSQ)' In April: Health Ministry
According to routine regulatory surveillance, the list of not of standard quality (NSQ) and spurious drugs is displayed on the CDSCO portal every month.
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
Central Drug Regulator Blames Tamil Nadu Lapses For Syrup Tragedy: Sources
The central drug regulator has blamed the negligence of Tamil Nadu authorities for the cough syrup tragedy.
-
Centre Flags Carcinogen Fears On Acidity Medicine Ranitidine, Orders Probe
The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure manufacturers of Ranitidine -- a commonly used acidity medicine --monitor NDMA levels.
-
India Proposes Training Programmes For Foreign Drug Regulators
India is likely to provide practical insights to certain countries on the best practices in drug regulations and the impactful initiatives taken by the Indian drug regulators, officials said on Wednesday.
-
Paracetamol, 50 Other Drug Samples Fail Quality Test. See Full List
Popular medications like paracetamol, pantoprazole and various antibiotics failed quality tests.
-
Centre Bans Anti-Cold Fixed Drug Combination In Children Below 4 Years
The Central Drugs Standard Control Organisation (CDSCO) has prohibited the use of anti-cold fixed drug combinations in children below four years of age.
-
Rajeev Singh Raghuvanshi Appointed As Drugs Controller General Of India
The Union Public Service Commission (UPSC) has recommended the name of DrRajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).
-
Drug Regulator Draws Johnson and Johnson Baby Powder Samples For Testing
The country's top drug regulator, the CDSCO, drew samples of Johnson and Johnson's baby powder from the company's Baddi plant in Himachal Pradesh on Wednesday amid reports that the product allegedly contained cancer-causing asbestos.
-
India's Reaction To Report On Johnson And Johnson Baby Powder
India's drug regulator said on Tuesday a news agency Reuters report that Johnson & Johnson knew for decades that cancer-causing asbestos lurked in its baby powder was "under consideration".
-
Pharma Firms Can Now Export Medicines, Devices Without 'No Objection Certificate'
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring "no-objection" certificate (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
-
Probe finds 'alarming' problems with India's drug regulator
India's main drug regulator has not been properly scrutinising some drugs before approving them, and some of its officials are colluding with drug firms and medical experts to circumvent procedure, according to a new parliamentary report. The report by parliament's health committee, the result of a more than year-long investigation, painted a chaot...
